Literature DB >> 32520581

Physiological and pharmacological perspectives of melatonin.

Saptadip Samanta1.   

Abstract

The pineal gland is a interface between light-dark cycle and shows neuro-endocrine functions. Melatonin is the primary hormone of pineal gland, secreted at night. The night-time melatonin peak regulates the physiological functions at dark. Melatonin has several unique features as it synchronises internal rhythm with daily and seasonal variations, regulates circadian rhythm and sleep-wake cycle. Physiologically melatonin involves in detoxification of free radicals, immune functions, neuro-protection, oncostatic effects, cardiovascular functions, reproduction, and foetal development. The precise functions of melatonin are exhibited by specific receptors. In relation to pathophysiology, impaired melatonin secretion promotes sleep disorder, cancer progression, type-2 diabetes, and neurodegenerative diseases. Several reports have highlighted the therapeutic benefits of melatonin specially related to cancer protection, sleep disorder, psychiatric disorders, and jet lag problems. This review will touch the most of the area of melatonin-oriented health impacts and its therapeutic aspects.

Entities:  

Keywords:  SCN; light-dark cycle; melatonin; pineal gland; therapeutic use

Year:  2020        PMID: 32520581     DOI: 10.1080/13813455.2020.1770799

Source DB:  PubMed          Journal:  Arch Physiol Biochem        ISSN: 1381-3455            Impact factor:   3.188


  4 in total

1.  Melatonin, an endogenous hormone, modulates Th17 cells via the reactive-oxygen species/TXNIP/HIF-1α axis to alleviate autoimmune uveitis.

Authors:  Jun Huang; Zhuang Li; Yunwei Hu; Zuoyi Li; Yanyan Xie; Haixiang Huang; Qian Chen; Guanyu Chen; Wenjie Zhu; Yuxi Chen; Wenru Su; Xiaoqing Chen; Dan Liang
Journal:  J Neuroinflammation       Date:  2022-05-27       Impact factor: 9.587

2.  Melatonin protects against apoptosis of megakaryocytic cells via its receptors and the AKT/mitochondrial/caspase pathway.

Authors:  Mo Yang; Liang Li; Shichao Chen; Suyi Li; Bo Wang; Changhua Zhang; Youpeng Chen; Liuming Yang; Hongwu Xin; Chun Chen; Xiaojun Xu; Qing Zhang; Yulong He; Jieyu Ye
Journal:  Aging (Albany NY)       Date:  2020-07-10       Impact factor: 5.682

3.  Chronological Age Interacts with the Circadian Melatonin Receptor 1B Gene Variation, Determining Fasting Glucose Concentrations in Mediterranean Populations. Additional Analyses on Type-2 Diabetes Risk.

Authors:  Jose V Sorlí; Rocío Barragán; Oscar Coltell; Olga Portolés; Eva C Pascual; Carolina Ortega-Azorín; José I González; Ramon Estruch; Carmen Saiz; Alejandro Pérez-Fidalgo; Jose M Ordovas; Dolores Corella
Journal:  Nutrients       Date:  2020-10-29       Impact factor: 5.717

4.  A Topical Formulation of Melatoninergic Compounds Exerts Strong Hypotensive and Neuroprotective Effects in a Rat Model of Hypertensive Glaucoma.

Authors:  Massimo Dal Monte; Maurizio Cammalleri; Rosario Amato; Salvatore Pezzino; Roberta Corsaro; Paola Bagnoli; Dario Rusciano
Journal:  Int J Mol Sci       Date:  2020-12-04       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.